Mechanisms controlling production of membrane and secreted immunoglobulin during B cell development

Immunologic Research

Volumn 37, Issue 1, 2007, Pages 33-46

  Peterson, Martha L ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Cleavage polyadenylation; Immunoglobulin mRNA; RNA processing regulation; RNA splicing

Indexed keywords

CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; IMMUNOGLOBULIN; RNA;

B LYMPHOCYTE; CELL MATURATION; GENE EXPRESSION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOGLOBULIN PRODUCTION; MICROARRAY ANALYSIS; MOLECULAR MODEL; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; REVIEW; RNA PROCESSING; RNA SPLICING;

ALTERNATIVE SPLICING; ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MEMBRANE; GENE EXPRESSION REGULATION; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULINS; MICE; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER;

EID: 34248338643     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02686094     Document Type: Review

References (100)

1. Lin Y, Wong K, Calame K: Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 1997;276:596-599.
2. Schliephake DE, Schimpl A: Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-μ F(ab′)2-costimulated B lymphocytes. Eur J Immunol 1996;26:268-271.
3. Turner CA, Jr, Mack DH, Davis MM: Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 1994;77:297-306.
4. Lin K-I, Angelin-Duclos C, Kuo TC, Calame K: Blimp-1-dependent repression of Pax-5 is required for differentialtion of B cells to immunogloblulin M-secreting plasma cells. Mol Cell Biol 2002;22:4771-4780.
5. Sciammas R, Davis MM: Modular nature of Blimp-1 in the regulation of gene expression during B cell maturation. J Immunol 2004;172:5427-5440.
6. Shaffer AL, Lin KI, Kuo TC, et al: Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002;17(1):51-62.
7. Yu J, Angelin-Duclos C, Greenwood J, Liao J, Calame K: Transcriptional repression by Blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol Cell Biol 2000;20:2592-2603.
8. Calame KL: Plasma cells: finding new light at the end of B cell development. Nat Immunol 2001;2(12):1103-1108.
9. Calame KL, Lin KI, Tunyaplin C: Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 2003;21:205-230.
10. Sciammas R, Davis MM: Blimp-1; Immunoglobulin secretion and the switch to plasma cells. Curr Top Microbiol Immunol 2005;290:201-224.
11. Shapiro-Shelef M, Calame K: Regulation of plasma-cell development. Nat Rev Immunol 2005;5(3):230-242.
12. Brewer JW, Hendershot LM: Building an antibody factory: a job for the unfolded protein response. Nat Immunol 2005;6(1):23-29.
13. Koshland ME: The immuoglobulin helper: the J chain; in: Honjo T, Alt FW, Rabbitts TH (eds): Immunoglobulin Genes. London, Academic Press, 1989, pp. 345-359.
14. Sidman C: B lymphocyte differentiation and the control of IgM mu chain expression. Cell 1981;23(2):379-389.
15. Hombach J, Sablitzky F, Rajewsky K, Reth M: Transfected plasmacytoma cells do not transport the membrane form of IgM to the cell surface. J Exp Med 1988;167(2):652-657.
16. Hombach J, Tsubata T, Leclercq L, Stappert H, Reth M: Molecular components of the B-cell antigen receptor complex of the IgM class. Nature 1990;343(6260):760-762.
17. Kelley DE, Perry RP: Transcriptional and post-transcriptional control of immunoglobulin mRNA production during B lymphocyte development. Nucleic Acids Res 1986;14:5431-5447.
18. Lamson G, Koshland ME: Changes in J chain and μ chain RNA expression as a function of B cell differentiation. J Exp Med 1984;160:877-892.
19. Perry RP, Kelley DE: Immunoglobulin messenger RNAs in murine cell lines that have characteristics of immature B lymphocytes. Cell 1979;18:1333-1339.
20. Yuan D, Tucker PW: Transcriptional regulation of μ-δ heavy chain locus in normal murine B lymphocytes. J Exp Med 1984;160:564-583.
21. Mason JO, Williams GT, Neuberger MS: The half-life of immunoglobulin mRNA increases during B-cell differentialion: a possible role for targeting to membrane-bound ribosomes. Genes Dev 1988;2:1003-1011.
22. Reed DJ, Hawley J, Dang T,Yuan D: Role of differential mRNA stability in the regulated expression of IgM and IgD. J Immunol 1994;152:5330-5336.
23. Jack HM, Wabl M: Immunoglobulin mRNA stability varies during B lymphocyte differentiation. EMBO J 1988;7(4):1041-1046.
24. Yuan D, Dang T: Regulation of μm vs μs mRNA expression in an inducible B cell line. Mol Immunol 1989;26:1059-1067.
25. Milcarek C, Suda-Hartman M, Croll SC: Changes in abundance of IgG 2a mRNA in the nucleus and cytoplasm of a murine B-lymphoma before and after fusion to a myeloma cell. Mol Immunol 1996;33:691-701.
26. Blattner FR, Tucker PW: The molecular biology of immunoglobulin D. Nature 1984;307:417-422.
27. Mather EL, Nelson KJ, Haimovich J, Perry RP: Mode of regulation of immunoglobulin μ and δ-chain expression varies during B-lymphocyte maturation. Cell 1984;35:329-338.
28. Maizels N: Immunoglobulin gene diversification. Annu Rev Genet 2005;39:23-46.
29. Alt FW, Bothwell ALM, Knapp M, et al: Synthesis of secreted and membrane-bound immunoglobulin mu heavy chains is directed by mRNAs that differ at their 3′ ends. Cell 1980;20:293-301.
30. Early P, Rogers J, Davis M, et al: Two mRNAs can be produced from a single immunoglobulin μ gene by alternative RNA processing pathways. Cell 1980;20:313-319.
31. Rogers J, Early P, Carter C, et al: Two mRNAs with different 3′ ends encode membrane-bound and secreted forms of immunoglobulin μ chain. Cell 1980;20:303-312.
32. Sharp PA: Split genes and RNA splicing. Cell 1994;77:805-815.
33. International HGSC: Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
34. Graveley BR: Sorting out the complexity of SR protein functions. RNA 2000;6:1197-1211.
35. Smith CWJ, Valcarcel J: Alternative pre-mRNA splicing: the logic of combinatorial control. TIBS 2000;25:381-388.
36. Garcia-Blanco MA, Baraniak AP, Lasda EL: Alternative splicing in disease and therapy. Nat Biotechnol 2004;22(5):535-546.
37. Edwalds-Gilbert G, Veraldi KL, Milcarek C: Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res 1997;25:2547-2561.
38. Peterson ML: RNA processing and expression of immunoglobulin genes; in: Snow EC, (ed): Handbook of B and T Lymphocytes. San Diego, Academic Press, 1994, pp. 321-342.
39. Peterson ML: Balanced efficiencies of splicing and cleavage- polyadenylation are required for μs and μm mRNA regulation. Gene Expr 1992;2:319-327.
40. Peterson ML, Bertolino S, Davis F: An RNA polymerase pause site is associated with the immunoglobulin μs poly(A) site. Mol Cell Biol 2002;22:5606-5615.
41. Peterson ML, Bingham GL, Cowan C: Multiple features contribute to the use of the immunoglobulin M secretion-specific poly(A) signal but are not required for developmental regulation. Mol Cell Biol 2006;26(18):6762-6771.
42. Peterson ML, Bryman MB, Peiter M, Cowan C: Exon size affects competition between splicing and cleavage-polyadenylation in the immunoglobulin μ gene. Mol Cell Biol 1994;14:77-86.
43. Peterson ML, Perry RP: Regulated production of μm and μs mRNA requires linkage of the poly(A) addition sites and is dependent on the length of the μs-μm intron. Proc Natl Sci USA 1986;83:8883-8887.
44. Peterson ML, Perry RP: The regulated production of μm and μs mRNA is dependent on the relative efficiencies of μs poly(A) site usage and the Cμ4-to-M1 splice. Mol Cell Biol 1989;9:726-738.
45. Peterson ML: Regulated immunoglobulin (Ig) RNA processing does not require specific cis-acting sequences: non-Ig genes can be alternatively processed in B cells and plasma cells. Mol Cell Biol 1994;14:7891-7898.
46. Seipelt RL, Spear BT, Snow EC, Peterson ML: A non-immunoglobulin transgene and the endogenous immunoglobulin μ gene are coordinately regulated by alternative RNA processing during B-cell maturation. Mol Cell Biol 1998;18:1042-1048.
47. Lassman CR, Milcarek C: Regulated expression of the mouse γ2b Ig H chain gene is influenced by poly(A) site order and strength. J Immunol 1992;148:2578-2585.
48. Flaspohler JA, Milcarek C: Myelomas and lymphomas expressing the Ig γ2a H chain gene have similar transcription termination regions. J Immunol 1990;144:2802-2810.
49. Lassman CR, Matis S, Hall BL, Toppmeyer DL, Milcarek C: Plasma cell-regulated polyadenylation at the Igμ2b secretion-specific poly(A) site. J Immunol 1992;148:1251-1260.
50. Flaspohler JA, Boczkowski D, Hall BL, Milcarek C: The 3′-untranslated region of membrane exon 2 from the gamma 2a immunoglobulin gene contributes to efficient transcription termination. J Biol Chem 1995;270(20):11903-11911.
51. Seipelt RL, Peterson ML: Alternative RNA processing of IgA pre-mRNA responds like IgM to alterations in the efficiency of the competing splice and cleavage-polyadenylation reactions. Mol Immunol 1995;32:277-285.
52. Lebman DA, Park MJ, Fatica R, Zhang Z: Regulation of usage of membrane and secreted 3′ termini of α mRNA differs from μ mRNA. J Immunol 1992;148:3282-3289.
53. Coyle JH, Borinstein SC, Woodward EO, Lebman DA: Predominant usage of the proximal poly(A) site in alpha mRNAs is not intrinsic to the 3′ termini. Int Immunol 1998;10(5):669-678.
54. Coyle JH, Lebman DA: Correct immunoglobulin α mRNA processing depends on specific sequence in the Cα3-αM intron. J Immunol 2000;164:3659-3665.
55. Burnside RD, Peterson ML: The IgA gene contains multiple RNA polymerase pause sites downstream of the secretory-specific poly(A) site. 2006, to be published.
56. Proudfoot NJ: How RNA polymerase II terminates transcription in higher eukaryotes. TIBS 1989;14:105-110.
57. Galli G, Guise JW, McDevitt MA, Tucker PW, Nevins JR: Relative position and strengths of poly(A) sites as well as transcription termination are critical to membrane versus secreted μ-chain expression during B-cell development. Genes Dev 1987;1:471-481.
58. Weiss EA, Michael A, Yuan D: Role of transcriptional termination in the regulation of μ mRNA expression in B lymphocytes. J Immunol 1989;143:1046-1052.
59. Tisch R, Kondo N, Hozumi N: Parameters that govern the regulation of immunoglobulin δ heavy-chain gene expression. Mol Cell Biol 1990;10:5340-5348.
60. Colgan DF, Manley JL: Mechanism and regulation of mRNA polyadenylation. Genes Dev 1997;11:2755-2766.
61. Zhao J, Hyman L, Moore C: Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 1999;63:405-445.
62. Berget S: Exon recognition in vertebrate splicing. J Biol Chem 1995;270:2411-2414.
63. Manley J, Tacke R: SR proteins and splicing control. Genes Dev 1996;10:1569-1579.
64. Krecic AM, Swanson MS: hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 1999;11:363-371.
65. Charlet BN, Logan P, Singh G, Cooper TA: Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol Cell 2002;9(3):649-658.
66. Mayeda A, Krainer AR: Regulation of alternative splicing by hnRNP A1 and splicing factor SF2. Cell 1992;68:365-375.
67. Matis SA, Martincic K, Milcarek C: B-lineage regulated polyadenylation occurs on weak poly(A) sites regardless of sequence composition at the cleavage and downstream regions. Nucleic Acids Res 1996;24:4684-4692.
68. Peterson ML, Gimmi ER, Perry RP: The developmentally regulated shift from membrane to secreted μ mRNA production is accompanied by an increase in cleavage-polyadenylation efficiency but no measurable change in splicing efficiency. Mol Cell Biol 1991;11:2324-2327.
69. Yan D-H, Weiss EA, Nevins JR: Identification of an activity in B-cell extracts that selectively impairs the formation of an immunoglobulin μs poly(A) site processing complex. Mol Cell Biol 1995;15(4):1901-1906.
70. Takagaki Y, Seipelt RL, Peterson ML, Manley JL: The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 1996;87:941-952.
71. Edwalds-Gilbert G, Milcarek C: Regulation of poly(A) site use during mouse B-cell development involves a change in the binding of a general polyadenylation factor in a B-cell stage-specific manner. Mol Cell Biol 1995;15(11):6420-6429.
72. Takagaki Y, Manley JL: Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation. Mol Cell 1998;2:761-771.
73. Takami Y, Kikuchi H, Nakayama T: Chicken histone deacetylase-2 controls the amount of the IgM H-chain at the steps of both transcription of its gene and alternative processing of its pre-mRNA in the DT40 cell line. J Biol Chem 1999;274:23977-23990.
74. Martincic K, Campbell R, Edwalds-Gilbert G, Souan L, Lotze MT, Milcarek C: Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the Go to S phase transition. Proc Natl Acad Sci USA 1998;95:11095-11100.
75. Veraldi KL, Arhin G, Martincic K, Chung-Ganster LH, Wilusz J, Milcarek C: hnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cells. Mol Cell Biol 2001;21:1228-1238.
76. Bagga PS, Arhin GK, Wilusz J: DSEF-1 is a member of the hnRNP H family of RNA-binding proteins and stimulates pre-mRNA cleavage and polyadenylation in vitro. Nucleic Acids Res 1998;26(23):5343-5350.
77. Matunis MJ, Xing J, Dreyfuss G: The hnRNP F protein: unique primary structure, nucleic acid-binding properties, and subcellular localization. Nucleic Acids Res 1994;22(6):1059-1067.
78. Caputi M, Zahler AM: Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H′/F/2H9 family. J Biol Chem 2001;276:43850-43859.
79. Phillips C, Jung S, Gunderson SI: Regulation of nuclear poly(A) addition controls the expression of immunoglobulin M secretory mRNA. EMBO J 2001;20(22):6443-6452.
80. Phillips C, Pachikara N, Gunderson SI: U1A inhibits cleavage at the immunoglobulin M heavy-chain secretory poly(A) site by binding between the two downstream GU-rich regions. Mol Cell Biol 2004;24(14):6162-6171.
81. Ma J, Gunderson SI, Phillips C: Non-snRNP U1A levels decrease during mammalian B-cell differentiation and release the IgM secretory poly(A) site from repression. RNA 2006;12(1):122-132.
82. Milcarek C, Martinçic K, Chung-Ganster L-H, Lutz CS: The snRNP-associated U1A levels change following IL-6 stimulation of human B cells. Mol Immunol 2003;39:809-814.
83. Tsurushita N, Ho L, Korn LJ: Nuclear factors in B lymphoma enhance splicing of mouse membrane-bound μ mRNA in Xenopus oocytes. Science 1988;239:494-497.
84. Bruce SR, Dingle RWC, Peterson ML: B-cell and plasma-cell splicing differences: a potential role in regulated immunoglobulin RNA processing. RNA 2003;9:1264-1273.
85. Niwa M, Berget SM: Mutation of the AAUAAA polyadenylation signal depresses in vitro splicing of proximal but not distal introns. Genes Dev 1991;5:2086-2095.
86. Niwa M, Rose SD, Berget SM: In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes Dev 1990;4:1552-1559.
87. Ashe MP, Griffin P, James W, Proudfoot NJ: Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site. Genes Dev 1995;9:3008-3025.
88. Furth P, Choe W, Rex J, Byrne JC, Baker C: Sequences homologous to 5′ splice sites are required for the inhibitory activity of papillomavirus late 3′ untranslated regions. Mol Cell Biol 1994;14:5278-5289.
89. Kornblihtt AR, de la Mata M, Fededa JP, Munoz MJ, Nogues G: Multiple links between transcription and splicing. RNA 2004;10(10):1489-1498.
90. Bentley D: Coupling RNA polymerase II transcription with pre-mRNA processing. Curr Opin Cell Biol 19;11:347-351.
91. Hirose Y, Manley JL: RNA polymerase II and the integration of nuclear events. Genes Dev 2000;14:1415-1429.
92. Proudfoot NJ: Connecting transcription to messenger RNA processing. Trends Biochem Sci 2000;25:290-293.
93. Proudfoot NJ, Furger A, Dye MJ: Integrating mRNA processing with transcription. Cell 2002;108:501-512.
94. Roberts GC, Gooding C, Mak HY, Proudfoot NJ, Smith CWJ: Co-transcriptional commitment to alternative splice site selection. Nucleic Acids Res 1998;26:5568-5572.
95. de la Mata M, Alonso CR, Kadener S, et al: A slow RNA polymerase II affects alternative splicing in vivo. Mol Cell 2003;12(2):525-532.
96. Robson-Dixon ND, Garcia-Blanco MA: MAZ elements alter transcription elongation and silencing of the fibroblast growth factor receptor 2 exon IIIb. J Biol Chem 2004;279:29075-29084.
97. Chalfant CE, Watson JE, Bisnauth LD, et al: Insulin regulates protein kinase CβII expression through enhanced exon inclusion in L6 skeletal muscle cells. J Biol Chem 1998;273:910-916.
98. van der Houven van Oordt W, Diaz-Meco MT, Lozano J, Krainer AR, Moscat J, Caceres JF: The MK3/6-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J Cell Biol 2000;149:307-316.
99. Alizadeh AA, Eisen MB, Davis RE, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403(6769):503-511.
100. Alizadeh A, Eisen M, Davis RE, et al: The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol 1999;64:71-78.